This paper is a meta-analysis of 30 published, double-blind clinical trials comparing
omeprazole with ranitidine or cimetidine for the treatment of duodenal ulcer, gastric ulcer …

Background: Short-term use of standard-dose proton pump inhibitors (PPIs) is the first-line
initial non-eradication treatment for duodenal ulcer (DU), but the choice on individual PPI …

Background: Rabeprazole sodium is the newest member of a class of substituted
benzimidazole molecules known as proton pump inhibitors. Other proton pump inhibitors …

Background: Lansoprazole is a new substituted benzimidazole that inhibits the H+, K+-
adenosine triphosphatase in the parietal cell and, like the first developed proton pump …

The present network meta‑analysis aimed to enhance the corresponding evidence with
respect to the efficacy and safety of pharmaceuticals treatments. Frequentist network meta …

Proton pump inhibitors decrease secretion of gastric acid. They act by blocking the last
enzyme in the system that actively transports acid from gastric parietal cells into the …

Since their introduction in 1976, and until recently, the H2-rcccptor antagonists have been
the'state-of-the-art'gastric acid inhibitors, but the advent of omeprazole, the acid pump …

A meta‐analysis was performed on pooled data from five large double‐blind studies (a total
of 1057 patients), which were conducted in Asia to compare the effects of omeprazole with …

Proton pump inhibitors (PPIs) have been established as the new" gold standard" for
traditional acid-inhibitory treatment of the so called" peptic" diseases. Due to the high …

Ten double-blind randomized studies with omeprazole versus ranitidine in duodenal ulcer
healing have been published. The total number of patients in the trials amounted to 2225. To …